38.41

0.26% -0.10

After Hours: 38.41

Atricure Inc (ATRC)

Overview News Price History Option Chain Financials Discussions Forecast

Atricure Inc stock is traded at $38.41, with a volume of 471.83K. It is down -0.26% in the last 24 hours and down -4.76% over the past month. AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Previous Close:

$38.51

Open:

$38.13

24h Volume:

471.83K

Relative Volume:

0.87

Market Cap:

$1.91B

Revenue:

$499.95M

Net Income/Loss:

$-36.36M

P/E Ratio:

-49.88

EPS:

-0.77

Net Cash Flow:

$24.22M

1W Performance:

-0.03%

1M Performance:

-4.76%

6M Performance:

+21.94%

1Y Performance:

-5.95%

1-Day Range:

$37.35

$39.28

1-Week Range:

$37.35

$40.91

52-Week Range:

$28.29

$43.18

Atricure Inc Stock (ATRC) Company Profile

Name

Atricure Inc

Sector

Healthcare (1114)

Industry

Medical Instruments & Supplies (58)

Phone

513-755-4100

Address

7555 INNOVATION WAY, MASON, OH

Employee

1,300

Twitter

@AtriCure

Next Earnings Date

2024-10-29

Latest SEC Filings

ATRC's Discussions on Twitter

Compare ATRC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ATRC Atricure Inc	38.41	1.91B	499.95M	-36.36M	24.22M	-0.77
ISRG Intuitive Surgical Inc	525.04	187.46B	10.06B	2.88B	2.27B	7.8807
BDX Becton Dickinson Co	203.40	57.96B	21.84B	1.68B	2.67B	5.8293
ALC Alcon Inc	80.87	39.68B	10.19B	1.05B	1.38B	2.1044
MDLN Medline Inc	46.31	37.32B	27.43B	1.27B	1.01B	1.5829
RMD Resmed Inc	255.50	37.29B	5.26B	1.44B	1.76B	9.7713

Atricure Inc Stock (ATRC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-17-24	Resumed	JP Morgan	Overweight
Apr-23-24	Upgrade	Oppenheimer	Perform → Outperform
Oct-23-23	Initiated	JMP Securities	Mkt Outperform
Sep-29-23	Initiated	UBS	Buy
Aug-05-21	Downgrade	Oppenheimer	Outperform → Perform
Dec-18-20	Reiterated	Needham	Buy
Nov-06-20	Reiterated	Needham	Buy
Apr-07-20	Initiated	Oppenheimer	Outperform
Feb-06-20	Initiated	BTIG Research	Buy
Jan-24-20	Reiterated	Needham	Buy
Aug-13-19	Downgrade	Northland Capital	Outperform → Market Perform
Apr-12-19	Initiated	JP Morgan	Overweight
Oct-04-18	Reiterated	Needham	Buy
Aug-02-18	Reiterated	Needham	Buy
Aug-02-18	Reiterated	Stifel	Buy
Jun-18-18	Reiterated	Needham	Buy
Apr-27-18	Reiterated	Needham	Buy
Jan-16-18	Reiterated	Needham	Buy
Nov-02-17	Reiterated	Needham	Buy
Jul-28-17	Reiterated	Needham	Buy
May-30-17	Resumed	Piper Jaffray	Overweight
Jun-30-16	Resumed	JMP Securities	Mkt Outperform
Oct-28-15	Reiterated	Needham	Buy
Oct-06-15	Reiterated	Canaccord Genuity	Buy
Oct-06-15	Reiterated	Needham	Buy

View All

Atricure Inc Stock (ATRC) Latest News

08:04 AM

Riverwater Partners LLC Buys 26,657 Shares of AtriCure, Inc. $ATRC - MarketBeat

08:04 AM

08:00 AM

AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results - Business Wire

08:00 AM

Jan 23, 2026

The Zacks Analyst Blog Highlights AtriCure, REV Group, Oceaneering International and Analog Devices - Yahoo Finance

Jan 23, 2026

Jan 21, 2026

Market Pulse: Is AtriCure Inc stock trending bullish2025 Investor Takeaways & Real-Time Volume Spike Alerts - baoquankhu1.vn

Jan 21, 2026

SG Americas Securities LLC Has $824,000 Position in AtriCure, Inc. $ATRC - MarketBeat

Jan 21, 2026

Jan 20, 2026

(ATRC) Risk Channels and Responsive Allocation - Stock Traders Daily

Jan 20, 2026

Jan 19, 2026

AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Jan 19, 2026

Jan 17, 2026

AtriCure (ATRC) Is Down 5.8% After Issuing 2026 Profitability Guidance And Expanding Credit Facility - Yahoo Finance

Jan 17, 2026

Jan 16, 2026

What are AtriCure Incs recent SEC filings showingMarket Growth Review & Long-Term Safe Return Strategies - baoquankhu1.vn

Jan 16, 2026

AtriCure CEO Touts $10B AFib and Pain Market, Raises EBITDA Outlook at JPMorgan Conference - MarketBeat

Jan 14, 2026

Momentum Shift: Is AtriCure Inc a potential multi baggerRate Cut & Reliable Price Action Trade Plans - baoquankhu1.vn

Jan 14, 2026

ATRC: Innovation and clinical evidence drive growth in AFib and pain management, with strong financial results - TradingView

Jan 14, 2026

Jan 13, 2026

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Boston Scientific (BSX) - The Globe and Mail

Jan 13, 2026

Street Watch: What is AtriCure Incs revenue forecastBear Alert & Low Risk Investment Opportunities - baoquankhu1.vn

Jan 13, 2026

AtriCure reports 13% revenue growth in Q4 2025, provides 2026 outlook - Investing.com Nigeria

Jan 13, 2026